DuPont Leader Updates 2013 Agriculture Research Pipeline with Investors

Tue Feb 26, 2013 9:03am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link

Agriculture & Nutrition Segments Spur Growth, Product Development Across Food
Value Chain
NEW YORK,  Feb. 26, 2013  /PRNewswire/ -- At the Goldman Sachs 17th  Annual
Agribusiness Conference today, DuPont Executive Vice President  James C. Borel 
highlighted 2013 growth drivers and advancements of its agriculture research
pipeline to sustain innovation across its seed, crop protection and nutrition
and health businesses.  Recent portfolio changes continue to solidify DuPont's
unique ability to address the global food security challenge by providing
solutions across the food value chain.

"Ongoing global dynamics like increased urbanization in developing economies and
consumer demand for protein-rich diets continue to strain today's agriculture
and food system.  Farmers, grocers and food manufacturers seek new innovations
to produce and package safe, nutritious food," said Borel.  "DuPont is uniquely
positioned to leverage science to provide options and local solutions that help
feed a growing global population."  

DuPont's recent acquisition of Danisco and full ownership of Solae further
strengthen the company's ability to bring new innovation and solutions to
customers across the food value chain.  

Borel discussed the 2013 agriculture research pipeline that features an
integrated approach to product development including germplasm, native and
biotech traits, with 12 product advancements including 4 program additions as a
result of sustained R&D efforts.

Following the strong commercial launches of Optimum AQUAmax hybrids, Optimum
AcreMax insect protection and Optimum AcreMax Xtra products in 2012, this year's
pipeline advancements underscore DuPont Pioneer's progress in bringing local
solutions to growers' biggest challenges.  Together with the solid growth of
DuPont Crop Protection's DuPont Rynaxypyr, and launches of DuPont Cyazypyr,
Dermacor seed treatment and Penthiopyrad, DuPont's Agriculture pipeline is
delivering today and poised for future growth.

"Our ability to unlock our strong seed germplasm potential using biotechnology,
sustainable chemistry profiles and leading nutrition science demonstrates DuPont
science at work for the global marketplace.  Our unique routes-to-market,
application development capabilities and local footprint ensures a close
relationship with growers and food companies alike to bring tangible solutions
from the ground up," Borel said.  

Borel used the  Brazil  corn business as an example of successful product
introductions combined with our advantaged route-to-market.  Using advanced
breeding and biotechnology, DuPont scientists have created unique products like
Optimum Intrasect, with two modes of action for lepidopteran insect control, and
early soybean varieties and corn hybrids uniquely designed to enable safrinha
double-cropping systems.  These high-yielding products with native and biotech
protection, delivered through our system of local sales professionals helped
DuPont Pioneer achieve a multi-point gain in corn market share in the  Brazil 
summer season and position us for continued growth in the current safrinha

To view a full copy of today's presentation, visit the "Events & Presentations"
page on the DuPont Investor Center.  

DuPont (NYSE: DD) has been bringing world-class science and engineering to the
global marketplace in the form of innovative products, materials, and services
since 1802.  The company believes that by collaborating with customers,
governments, NGOs, and thought leaders we can help find solutions to such global
challenges as providing enough healthy food for people everywhere, decreasing
dependence on fossil fuels, and protecting life and the environment.  For
additional information about DuPont and its commitment to inclusive innovation,
please visit  

Forward-Looking Statements: This news release contains forward-looking
statements based on management's current expectations, estimates and
projections. The company does not undertake to update any forward-looking
statements as a result of future developments or new information. All statements
that address expectations or projections about the future, including statements
about the company's strategy for growth, product development, market position,
expected expenditures and financial results are forward-looking statements. Some
of the forward-looking statements may be identified by words like "expects,"
"anticipates," "plans," "intends," "projects," "indicates," and similar
expressions. These statements are not guarantees of future performance and
involve a number of risks, uncertainties and assumptions. Many factors,
including those discussed more fully elsewhere in this release and in DuPont's
filings with the Securities and Exchange Commission, particularly its latest
annual report on Form 10-K, as well as others, could cause results to differ
materially from those stated. These factors include, but are not limited to
changes in the laws, regulations, policies and economic conditions of countries
in which the company does business; competitive pressures; successful
integration of structural changes, including acquisitions, divestitures and
alliances; research and development of new products, including regulatory
approval and market acceptance, and seasonality of sales of agricultural

The DuPont Oval Logo, DuPont, Optimum, AQUAmax, AcreMax, Intrasect, Rynaxypyr,
Cyazypyr and Dermacor are trademarks or registered trademarks of DuPont or its


Jennifer Goldston, +1-515-535-5774,

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.